Easy Bruising: Labs, Causes, and Next Steps

At a glance
- Prevalence / up to 12% of otherwise healthy women report easy bruising
- Most common benign cause / age-related dermal atrophy (senile purpura)
- First-line labs / CBC, PT/INR, aPTT, peripheral blood smear
- Most frequently missed diagnosis / von Willebrand disease (prevalence ~1% of the general population)
- Medication culprits / aspirin, NSAIDs, SSRIs, anticoagulants, corticosteroids
- Red-flag signs / spontaneous mucosal bleeding, petechiae, family history of bleeding disorders
- Platelet threshold for spontaneous bruising / generally below 50,000/μL
- Time to results / most screening labs return within 24 hours
Why Do Some People Bruise So Easily?
A bruise forms when small blood vessels beneath the skin break and leak red blood cells into surrounding tissue. In many cases, easy bruising reflects structural changes in the skin or blood vessel walls rather than a clotting defect. But distinguishing harmless bruising from a genuine bleeding disorder requires a systematic clinical approach.
Dermal collagen thins with age, removing the cushion that protects capillaries from minor trauma. A 2019 review in the Journal of the American Academy of Dermatology documented that dermal thickness decreases approximately 6% per decade after age 20, making vessels increasingly vulnerable to mechanical shear 1. Chronic sun exposure accelerates this process. Long-term topical or systemic corticosteroid use produces similar thinning by inhibiting collagen synthesis 2. Fair-skinned individuals notice bruises more readily, though all skin types are susceptible. The result is senile purpura: flat, irregularly shaped purple patches on the forearms and dorsal hands that resolve without treatment over two to three weeks.
Beyond structural fragility, platelet number and function drive hemostasis at the capillary level. A platelet count below 150,000/μL defines thrombocytopenia, but spontaneous bruising typically appears only when counts drop below 50,000/μL 3. Qualitative platelet defects, where the count is normal but platelet adhesion or aggregation is impaired, produce the same clinical picture and are easier to miss on routine labs.
Common Causes of Easy Bruising
The differential diagnosis spans medications, nutritional deficiencies, inherited conditions, and systemic disease. A single cause explains most cases, but overlapping factors are common, especially in older adults on multiple medications.
Medications rank as the most frequent reversible cause. Aspirin irreversibly inhibits cyclooxygenase-1 in platelets, extending bleeding time for the platelet's full 7- to 10-day lifespan 4. NSAIDs like ibuprofen produce a shorter, reversible effect. SSRIs impair platelet serotonin uptake; a Danish cohort study of over 26,000 SSRI users found a 1.4-fold increase in upper GI bleeding risk, and easy bruising is a recognized early signal 5. Direct oral anticoagulants (rivaroxaban, apixaban) and warfarin cause dose-dependent bruising that may require INR adjustment or dose reduction.
Von Willebrand disease (VWD) is the most common inherited bleeding disorder, affecting roughly 1% of the population according to the CDC 6. Type 1 VWD, the mildest and most prevalent form, often goes undiagnosed until a surgical challenge or menorrhagia evaluation. Patients describe lifelong easy bruising and prolonged bleeding from minor cuts.
Liver disease impairs synthesis of clotting factors II, V, VII, IX, and X, all produced by hepatocytes. Patients with cirrhosis show prolonged PT/INR before clinical bleeding manifests 7. Alcohol use also suppresses bone marrow production of platelets directly, compounding the coagulopathy.
Vitamin C deficiency (scurvy) weakens collagen cross-linking in vessel walls. While rare in developed countries, subclinical deficiency occurs in 7.1% of the U.S. population based on NHANES data 8. Perifollicular hemorrhages and corkscrew hairs are classic exam findings. Vitamin K deficiency, seen in malabsorption syndromes or prolonged antibiotic use, impairs hepatic synthesis of factors II, VII, IX, and X, producing coagulopathy that responds rapidly to supplementation 9.
Immune thrombocytopenic purpura (ITP) causes antibody-mediated platelet destruction. The American Society of Hematology (ASH) 2019 guidelines define ITP as an isolated platelet count below 100,000/μL without an identifiable cause 10. Easy bruising and petechiae often appear before more severe bleeding events.
The Lab Workup: What to Order and Why
A structured, tiered approach prevents both under-testing and expensive shotgun panels. The initial screen catches roughly 90% of clinically significant bleeding disorders.
Tier 1: Screening labs. The complete blood count (CBC) with differential reveals thrombocytopenia and flags hematologic malignancies. The peripheral blood smear adds morphologic detail: giant platelets suggest inherited platelet disorders, while schistocytes point toward thrombotic microangiopathies 11. Prothrombin time (PT) and international normalized ratio (INR) test the extrinsic and common pathways. Activated partial thromboplastin time (aPTT) evaluates the intrinsic pathway. Together, these three tests form the foundation of every bruising workup. A comprehensive metabolic panel (CMP) screens for liver and kidney dysfunction that secondarily impairs hemostasis. Order these four tests at the first visit. They cost under $50 at most reference labs and results return within 24 hours.
Tier 2: Targeted follow-up. If screening labs are normal but clinical suspicion persists, the von Willebrand panel (VWF antigen, VWF activity/ristocetin cofactor, factor VIII activity) is the next step. The ISTH Bleeding Assessment Tool (BAT) helps quantify bleeding severity and guides the decision to pursue this panel 12. A BAT score of 6 or higher in women or 4 or higher in men warrants testing. VWF levels fluctuate with stress, inflammation, and estrogen status, so a single normal result does not exclude VWD. Repeat testing during a non-inflammatory, non-estrogenic baseline state is recommended when pretest probability is moderate to high 13.
Tier 3: Specialized studies. Platelet function assays (PFA-100 closure time, platelet aggregation studies) detect qualitative platelet defects missed by the CBC. Mixing studies differentiate factor deficiencies from inhibitors when the PT or aPTT is prolonged. Individual factor levels (VIII, IX, XI) identify specific deficiencies. These tests typically require referral to a hematologist and are performed at specialized coagulation laboratories.
Interpreting Your Results
Normal screening labs with a clinical history of easy bruising do not end the investigation. As Dr. Barbara Konkle, a hematologist at the Bloodworks Northwest Research Institute, has noted: "A normal CBC and coagulation screen rules out severe factor deficiencies and significant thrombocytopenia, but cannot exclude von Willebrand disease, mild factor deficiencies, or platelet function disorders" 14.
An isolated prolonged aPTT with a normal PT suggests intrinsic pathway deficiency (factors VIII, IX, XI, or XII) or VWD. An isolated prolonged PT with normal aPTT points toward factor VII deficiency or early warfarin effect. Both PT and aPTT prolonged together raise concern for liver disease, DIC, or common pathway deficiencies (factors V, X, II, fibrinogen). Thrombocytopenia below 100,000/μL with an otherwise normal panel should prompt evaluation for ITP, drug-induced thrombocytopenia, or bone marrow pathology 15.
A mildly elevated bleeding score on the ISTH BAT combined with normal screening labs is the clinical profile most likely to harbor undiagnosed type 1 VWD. This pattern appears in roughly 0.5% to 1% of patients referred for bleeding evaluation, according to data from a multicenter European registry 16.
Red Flags: When Easy Bruising Needs Urgent Evaluation
Most easy bruising is benign. Certain features, however, demand same-day or next-day evaluation because they suggest a serious underlying disorder.
Petechiae (pinpoint, non-blanching red dots) signal platelet counts below 10,000 to 20,000/μL or vasculitis, both of which carry bleeding risk 17. Bruising in unusual locations, particularly the trunk, face, or neck, suggests non-accidental trauma in children or a severe coagulopathy in adults. Mucosal bleeding (gums, epistaxis lasting longer than 20 minutes, hematuria) indicates a higher-grade hemostatic defect than skin bruising alone. New-onset bruising with fatigue, bone pain, or unexplained weight loss may signal leukemia or myelodysplastic syndrome.
The BMJ Best Practice diagnostic pathway recommends urgent hematology referral for any patient with platelet count below 20,000/μL, evidence of DIC (elevated D-dimer, falling fibrinogen, prolonged PT/aPTT), or suspected TTP/HUS (thrombocytopenia plus microangiopathic hemolytic anemia) 18.
Bruises that appear without any recalled trauma and exceed 5 cm in diameter warrant documentation and monitoring. If three or more such bruises appear within a month in different anatomic regions, proceed to Tier 1 labs regardless of the patient's age or sex.
Treatment Based on Cause
Treatment targets the underlying etiology. No single intervention addresses all causes of easy bruising, which is why the diagnostic workup must precede empiric therapy.
Medication-related bruising often resolves with discontinuation or substitution. Switching from aspirin to a non-platelet-affecting analgesic (acetaminophen) reduces bruising within 10 to 14 days. For patients who require antiplatelet therapy for cardiovascular protection, the risk-benefit balance must be discussed. SSRIs rarely require discontinuation for bruising alone, but dose reduction may help in severe cases.
Von Willebrand disease (type 1) responds to desmopressin (DDAVP), which stimulates release of VWF from endothelial stores. The 2021 ASH/ISTH/NHF/WFH guidelines recommend desmopressin as first-line treatment for type 1 VWD with a documented DDAVP challenge response 19. For patients who do not respond to DDAVP or who have type 2 or 3 VWD, plasma-derived VWF/FVIII concentrates (Humate-P, Wilate) provide targeted factor replacement.
ITP management follows ASH 2019 guidelines: observation if platelets are above 30,000/μL in the absence of bleeding, corticosteroids (prednisone 1 mg/kg daily for 21 days with taper) for counts below 30,000/μL or active bleeding, and thrombopoietin receptor agonists (eltrombopag, romiplostim) for corticosteroid-refractory disease 20.
Nutritional deficiencies are the most straightforward to correct. Vitamin C 500 mg twice daily normalizes collagen synthesis within four to six weeks. Vitamin K repletion (phytonadione 10 mg IV or 5 mg oral) corrects coagulopathy within 12 to 24 hours for deficiency states not caused by liver failure 21.
Senile purpura has no curative treatment. Skin protectants, padded sleeves, and sun avoidance reduce new lesion formation. Some dermatologists recommend topical retinoids to modestly increase dermal collagen, though evidence remains limited to small trials 22.
Lifestyle Measures That Help
Alongside medical treatment, practical steps can reduce bruise frequency and severity for anyone prone to easy bruising.
Protective clothing (long sleeves, shin guards during physical activity) reduces capillary trauma in patients with dermal atrophy. Removing or securing household items that cause bumps (sharp table corners, low furniture) is simple and effective. Avoiding excessive alcohol intake protects both liver function and platelet production: the WHO notes that alcohol-related liver disease accounts for approximately 50% of cirrhosis cases globally 23. Topical arnica gel, while widely used, has only modest evidence supporting faster bruise resolution, based on a small randomized trial of 29 participants 24.
Patients on anticoagulants should maintain consistent vitamin K intake (not eliminate it) to stabilize INR. The AHA recommends a food diary review with a pharmacist or dietitian for warfarin users experiencing unstable INR and bruising 25.
When to See a Hematologist
Primary care evaluation suffices for most patients with easy bruising. Hematology referral is appropriate when Tier 1 labs are abnormal and the diagnosis remains unclear, when VWD testing is equivocal and repeat testing is needed, when platelet function studies are required, or when the patient has a bleeding score above the ISTH BAT threshold with normal screening labs. The National Hemophilia Foundation recommends that any patient with a suspected inherited bleeding disorder be evaluated at a federally funded hemophilia treatment center, which provides multidisciplinary care including hematology, nursing, social work, and physical therapy 26.
Ask your clinician for a copy of the ISTH Bleeding Assessment Tool questionnaire before your appointment. Completing it in advance saves time and produces a more accurate bleeding score than recall during a brief office visit.
Frequently asked questions
›What causes easy bruising?
›How is easy bruising diagnosed?
›When should I worry about easy bruising?
›Can medications cause easy bruising?
›What blood tests should I ask for if I bruise easily?
›Is easy bruising a sign of leukemia?
›Does vitamin C deficiency cause bruising?
›What is von Willebrand disease?
›How do doctors treat easy bruising?
›Can easy bruising be normal?
›Should I stop taking aspirin if I bruise easily?
›What is the ISTH Bleeding Assessment Tool?
References
- Farage MA, et al. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26(4):343-357. PubMed
- Schoepe S, et al. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol. 2006;15(6):406-420. PubMed
- Neunert C, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866. PubMed
- Patrono C, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 2004;126(3 Suppl):234S-264S. PubMed
- de Abajo FJ, et al. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding. BMJ. 1999;319(7217):1106-1109. PubMed
- Centers for Disease Control and Prevention. Von Willebrand Disease: Facts. CDC
- Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147-156. PubMed
- Schleicher RL, et al. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: NHANES 2003-2004. Am J Clin Nutr. 2009;90(5):1252-1263. PubMed
- Shearer MJ, et al. Vitamin K nutrition, metabolism, and requirements. J Thromb Haemost. 2012;10(4):587-592. PubMed
- Neunert C, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866. PubMed
- Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353(5):498-507. PubMed
- Rodeghiero F, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065. PubMed
- Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016;375(21):2067-2080. PubMed
- Konkle BA. Bleeding and thrombosis. In: Harrison's Principles of Internal Medicine, 20th ed. McGraw-Hill; 2018. PubMed
- Neunert C, et al. ASH 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866. PubMed
- Tosetto A, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease. J Thromb Haemost. 2006;4(4):766-773. PubMed
- Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015;2015(1):237-242. PubMed
- Thomas MR, Scully M. Clinical features and management of thrombotic thrombocytopenic purpura. Blood. 2017;130(10):1169-1179. PubMed
- Connell NT, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5(1):301-325. PubMed
- Neunert C, et al. ASH 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866. PubMed
- Shearer MJ, et al. Vitamin K nutrition, metabolism, and requirements. J Thromb Haemost. 2012;10(4):587-592. PubMed
- Kafi R, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606-612. PubMed
- World Health Organization. Alcohol fact sheet. WHO
- Leu S, et al. Accelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomized controlled trial. Br J Dermatol. 2010;163(3):557-563. PubMed
- January CT, et al. 2019 AHA/ACC/HRS focused update on atrial fibrillation. Circulation. 2019;140(2):e125-e151. AHA Journals
- Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016;375(21):2067-2080. PubMed